Heart pill may fight deadly blood infection
NCT ID NCT06650488
Summary
This study is testing if switching from aspirin to a different blood thinner, clopidogrel, helps patients recover better from serious Staphylococcus aureus (Staph) bloodstream infections. It will enroll 300 patients who are already taking aspirin to prevent heart problems. Researchers want to see if clopidogrel, which might have some anti-Staph properties, leads to fewer complications and deaths compared to staying on aspirin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS ENDOCARDITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital)
RECRUITINGMontreal, Quebec, H4A3S1, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.